{"version":"1.0","type":"link","title":"Relative dose intensity of gemcitabine-nab-paclitaxel combination as second-line or more in locally advanced or metastatic pancreatic adenocarcinoma.","author_name":"Grancher A 외","author_url":"https://prs-insight.online/author/Grancher%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/153408","thumbnail_width":1200,"thumbnail_height":630}